PMC:7212965 / 1784-1966 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":4,"end":11},"obj":"Body_part"},{"id":"T7","span":{"begin":175,"end":180},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma82749"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver a"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T6","span":{"begin":175,"end":180},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver a"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":"and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver a"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":175,"end":180},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T18","span":{"begin":175,"end":180},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver a"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":4,"end":11},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_16449"}],"text":"and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver a"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T11","span":{"begin":144,"end":152},"obj":"Phenotype"},{"id":"T12","span":{"begin":154,"end":169},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0002017"}],"text":"and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver a"}

{"project":"LitCovid-PubTator","denotations":[{"id":"62","span":{"begin":144,"end":152},"obj":"Disease"},{"id":"63","span":{"begin":154,"end":160},"obj":"Disease"},{"id":"64","span":{"begin":161,"end":169},"obj":"Disease"}],"attributes":[{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:D003967"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D009325"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D014839"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver a"}